Categories
Topics

EPFL spinoff QGel raises 12 million dollars from private investors, december 12, 2016

Deactivate selection mode Select images

The selection mode is now active. Click on the images you wish to download and choose an action below

QGel is a startup that makes a synthetic gel for growing cells as if they were in the human body. This breakthrough enhances the reliability of research into anti-cancer drugs. The company has just announced that it has raised 12 million dollars from private investors, which will allow it to expand its product range. Colin Sanctuary. December 12, 2016 QGel is a startup that makes a synthetic gel for growing cells as if they were in the human body. This breakthrough enhances the reliability of research into anti-cancer drugs. The company has just announced that it has raised 12 million dollars from private investors, which will allow it to expand its product range. Colin Sanctuary. December 12, 2016 QGel is a startup that makes a synthetic gel for growing cells as if they were in the human body. This breakthrough enhances the reliability of research into anti-cancer drugs. The company has just announced that it has raised 12 million dollars from private investors, which will allow it to expand its product range. Colin Sanctuary. December 12, 2016 QGel is a startup that makes a synthetic gel for growing cells as if they were in the human body. This breakthrough enhances the reliability of research into anti-cancer drugs. The company has just announced that it has raised 12 million dollars from private investors, which will allow it to expand its product range. Colin Sanctuary. December 12, 2016 QGel is a startup that makes a synthetic gel for growing cells as if they were in the human body. This breakthrough enhances the reliability of research into anti-cancer drugs. The company has just announced that it has raised 12 million dollars from private investors, which will allow it to expand its product range. Colin Sanctuary. December 12, 2016 QGel is a startup that makes a synthetic gel for growing cells as if they were in the human body. This breakthrough enhances the reliability of research into anti-cancer drugs. The company has just announced that it has raised 12 million dollars from private investors, which will allow it to expand its product range. Colin Sanctuary. December 12, 2016 QGel is a startup that makes a synthetic gel for growing cells as if they were in the human body. This breakthrough enhances the reliability of research into anti-cancer drugs. The company has just announced that it has raised 12 million dollars from private investors, which will allow it to expand its product range. Colin Sanctuary. December 12, 2016